Marshall Wace, LLP Centogene N.V. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
BUY
$9.02 - $12.93 $168,592 - $241,674
18,691 New
18,691 $195,000

Others Institutions Holding CNTG

# of Institutions
2
Shares Held
33.6K
Call Options Held
0
Put Options Held
0
View Full List

About Centogene N.V.

CNTG Quotes by TradingView
  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email